期刊文献+

佐米曲普坦在不同pH条件下的平衡溶解度和表观油水分配系数 被引量:8

Determination of equilibrium solubility of zolmitriptan and its apparent oil/water partition coefficient
在线阅读 下载PDF
导出
摘要 目的:测定佐米曲普坦在水和不同pH磷酸缓冲盐中的平衡溶解度以及在正辛醇-水和正辛醇-缓冲液体系中的表观油水分配系数。方法:采用HPLC法测定佐米曲普坦的浓度,用摇瓶法测定佐米曲普坦的表观油水分配系数。结果:佐米曲普坦在37℃水中的平衡溶解度为12.6g/L,在pH值3.6、4.5、6.0、6.8、7.4、8.0、9.0磷酸盐缓冲液中的平衡溶解度依次为1382.0、553.0、85.2、71.5、47.1、11.5、4.85g/L。佐米曲普坦在水中的表观油水分配系数Papp为0.013,在不同的pH值缓冲液中的表观油水分配系数依次为0.04、0.06、0.14、0.20、0.23、0.25、1.44。结论:在pH3.6~9.0范围内,随着pH值增加,佐米曲普坦平衡溶解度减小,而表观油水分配系数则增大。 Objective:To determine the equilibrium solubility of zolmitriptan in various media and its partition coefficients for the n-octanol-water/buffer solution systems.Methods:A high performance liquid chromatography was established and used to detect the concentration of zolmitriptan;the partition coefficients for the n-octanol-water/buffer solution systems of zolmitriptan were determined by shaking flask method.Results:The equilibrium solubility of zolmitriptan in water was 12.6 g/L at 37℃.The equilibrium solubility of zolmitriptan were 1 382.0,553.0,85.2,71.5,47.1,11.5 and 4.85 g/L in buffer solutions with pH values of 3.6,4.5,6.0,6.8,7.4,8.0 and 9.0 respectively.Papp of zolmitriptan was 0.013 in water and were 0.04,0.06,0.14,0.20,0.23,0.25 and 1.44 in buffer solutions with different pH values.Conclusion:In the range of pH3.6 to pH 9.0,the equilibrium solubility of zolmitriptan was decreased while the apparent oil/water partition coefficient was increased with the increasing of pH values.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2010年第8期1235-1237,共3页 Journal of Chongqing Medical University
关键词 佐米曲普坦 平衡溶解度 表观油水分配系数 高效液相色谱法 Zolmitriptan Equilibrium solubility Apparent oil/water partition coefficient High performance liquid chromatography.
作者简介 作者介绍:胡荣(1979-),女,硕士,研究方向:速释及缓控释制剂的研究。 通讯作者:黄华,女,教授,E-mail:huangh60@tom.com。
  • 相关文献

参考文献7

二级参考文献28

  • 1蒋山好 朱元龙 朱任宏.中国乌头的研究XX·赣皖乌头的研究[J].药学学报,1982,17(4):288-288.
  • 2Wang XW.Elemene[J].Drugs of the future,1998,23(3):266-270.
  • 3国家食品药品监督管理局药品评审中心等主编.药物临床信息参考,第一版.重庆:四川科学技术出版社,2004:602.
  • 4MORIKAWA T,MATSUZAWA Y,MAKITA K,et al.Antimigraine drug zolmitrlptan,inhibits high-voltage activated calium currents in a population of acutely dissociated rat trigeminal sensory neurons[J].Mol Pain,2006,2:10-15.
  • 5BERGSTROM M,YATES R,WALL A,et al.Blood-brain barrier penetration of zolmitriptan-modelling of positron emission tomography data[J].J Pharmacokinet Pharmacodyn,2006,33(1):75-91.
  • 6KAPOPORT AM,BIGAL ME,TEPPER SJ,et al.Zolmitriptan(Zomig)[J].Neurotherapeutics,2004,40(1):33-41.
  • 7SHEPHEARD SL,WILLIAMSON DJ,COOK DA,et al.Preclinical comparative studies on the sympatholytic effects of 5-HT1 D receptor agonists in vivo Headache Treatment[M]//OLESEN J,TFELT-HANSEN P.Trial Methodology and New Trials.Lippincot-Raven,PA,USA,1997:293-302.
  • 8DIXON R,GILLATIN C,GIBBENS M,et al.The pharmacokinetics and effects on blood pressure of multiple doses of the novel antimigraine drug Zolmitriptan(311C90)in healthy volunteers[J].Br J Clin Pharmacol,1997,43(3):273-281.
  • 9SEABER EJ,PECK RW,SMITH DA,et al.Absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers[J].Br J Clin Pharmacol,1998,46(5):433-439.
  • 10DOWSON AJ,CHARLESWORTH B.A view of zolmitriptan and its clinical applications in migraine[J].Expert Opin Pharmacother,2002,3(7):993-1005.

共引文献95

同被引文献93

引证文献8

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部